<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250524065864N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-27</date_registration>
      <primary_sponsor>Faisalabad medical university</primary_sponsor>
      <public_title>Comparing the risk of post-surgery delirium in older adults: sevoflurane vs propofol anesthesia</public_title>
      <acronym></acronym>
      <scientific_title>The comparative analysis of post-operative delirium incidence: sevoflurane vs propofol in geriatric patients under general anaesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-12-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>200</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/83767</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Length of hospital stay, Severity and duration of Post Op delirium, Randomization description: This study was designed as a randomized controlled trial (RCT) to compare the incidence of post-operative delirium (POD) in geriatric patients undergoing surgery under general anesthesia with either propofol or sevoflurane. Eligible participants were randomly assigned to one of two groups: Group A received propofol-based general anesthesia, while Group B received sevoflurane-based general anesthesia. Randomization was performed using a computer-generated sequence to ensure equal and unbiased allocation, with allocation concealment maintained to minimize selection bias. Post-operatively, all patients were closely monitored for signs of delirium using a validated assessment tool, such as the Confusion Assessment Method (CAM). The primary outcome measured was the incidence of POD within 72 hours after surgery. This randomized design enabled a direct and unbiased comparison of the effects of propofol and sevoflurane on the development of post-operative delirium in older surgical patients, Blinding description: This study was designed as a single-blinded randomized controlled trial (RCT) to compare the incidence of post-operative delirium (POD) in geriatric patients undergoing surgery under general anesthesia with either propofol or sevoflurane. Eligible participants were randomly assigned to one of two groups: Group A received propofol-based general anesthesia, while Group B received sevoflurane-based general anesthesia. Randomization was performed using a computer-generated sequence to ensure equal and unbiased allocation, with allocation concealment maintained to minimize selection bias. In this single-blinded design, patients were unaware of the type of anesthesia they received, while the anesthesia providers were informed due to the nature of drug administration. Post-operatively, all patients were closely monitored for signs of delirium using a validated assessment tool, such as the Confusion Assessment Method (CAM). The primary outcome measured was the incidence of POD within 72 hours after surgery. This randomized and blinded design allowed for a more objective and unbiased comparison of the effects of propofol and sevoflurane on the development of post-operative delirium in older surgical patients.</study_design>
      <phase>2</phase>
      <hc_freetext>Post-operative delirium (POD) is a common and serious complication that occurs after surgery, particularly in older adults. It is characterized by an acute and fluctuating disturbance in attention, awareness, and cognition, typically arising within the first few days following anesthesia and surgery. POD can manifest as confusion, disorientation, memory disturbances, hallucinations, or agitation, and may vary in intensity and duration. It is associated with increased morbidity, prolonged hospital stays, higher healthcare costs, and a greater risk of long-term cognitive decline or institutionalization. Various factors contribute to the development of POD, including advanced age, pre-existing cognitive impairment, type of surgery, and the choice of anesthetic agents. Early detection and appropriate management are essential to improving patient outcomes and minimizing the impact of this condition..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Group A received sevoflurane-based anesthesia, while Group B received propofol-based anesthesia. All participants were induced with intravenous propofol (1–2 mg/kg), nalbuphine (0.1–0.2 mg/kg), and atracurium (0.5 mg/kg).Anesthesia in Group A was maintained using inhaled sevoflurane, titrated to achieve a BIS value between 40 and 60. Intervention 2: Intervention group: Group B received target-controlled infusion (TCI) of propofol to maintain a BIS value within the same range. Muscle relaxation in both groups was maintained with continuous atracurium infusion (10 μg/kg/min).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is currently no plan to make deidentified individual participant data (IPD) available due to concerns regarding patient privacy, lack of infrastructure for secure data sharing, or institutional restrictions.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Humaira Ahmad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Masjid Ismail Rd, Faisalabad</address>
        <city>Faisalabad</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 333 5824895</telephone>
        <email>Humaira_ahmad21@hotmail.com</email>
        <affiliation>Allied Hospital faisalabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Ammara Liaqat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Masjid Ismail Rd, Faisalabad</address>
        <city>Faisalabad</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 332 1752600</telephone>
        <email>Ammaraliaqat22@gmail.com</email>
        <affiliation>Allied Hospital Faisalabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Both gender
60-90
Patients undergoing for Mild to moderate risk elective surgery
American society of Anesthesiology (ASA) I-III</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>90 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patient with preoperative delirium
History of dementia
Psychiatric disease like schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis
Hepatic or renal dysfunction
Requirement for postoperative mechanical ventilation
Allergy to any of the study drugs
History of surgery within the recent six months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F05.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Post-operative delirium (POD) is a common and serious complication that occurs after surgery, particularly in older adults. It is characterized by an acute and fluctuating disturbance in attention, awareness, and cognition, typically arising within the fi</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Group A received sevoflurane-based anesthesia, while Group B received propofol-based anesthesia. All participants were induced with intravenous propofol (1–2 mg/kg), nalbuphine (0.1–0.2 mg/kg), and atracurium (0.5 mg/kg).Anesthesia in Group A was maintained using inhaled sevoflurane, titrated to achieve a BIS value between 40 and 60.</i_keyword>
      <i_keyword>Intervention group: Group B received target-controlled infusion (TCI) of propofol to maintain a BIS value within the same range. Muscle relaxation in both groups was maintained with continuous atracurium infusion (10 μg/kg/min)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Post Operative Delirium. Timepoint: During the first seven post-operative days, delirium will be assessed twice each day, that is, between 8–10 am and 6–8 pm, by using CAM. Delirium will be assessed as per operational definition. All the information will be recorded on performa by myself. Method of measurement: Confusion Assessment Method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Reduce hospital stay and better outcomes. Timepoint: During the first seven post-operative days, delirium will be assessed twice each day, that is, between 8–10 am and 6–8 pm, by using CAM. Method of measurement: Confusion Assessment Method (CAM).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Faisalabad medical university</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-12-05</approval_date>
        <contact_name>Secretariat Ethical Review Committee National lnstitute of Heatth, Research Centre</contact_name>
        <contact_address>Ground Floor Anatomy Department Faisalabad medical university Faisalabad Faisalabad Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
